Comparison of two estrus-synchronization protocols and timed artificial insemination in dairy cattle.
The objective of this study was to evaluate the effect of the Ovsynch protocol with and without exogenous progesterone on pregnancy rate (PR) in cows in which estrous cycles were previously synchronized with 2 doses of PGF(2alpha) and that were not detected in estrus during the presynchronization period. The study was conducted in Chihuahua, Mexico (8,650 Holstein milking cows; 305-d mature equivalent milk yield = 13,790 kg). On d 47 postpartum, estrous cycles in cows were synchronized by using 2 doses of PGF(2alpha) 14 d apart. Any cow detected in estrus during this presynchronization period was inseminated. Cows not detected in estrus were selected at random and assigned to receive progesterone supplementation or to serve as controls. Controls (n = 594) were subjected to the Ovsynch protocol and cows in the progesterone supplemented treatment (n = 594) were subjected to the Ovsynch protocol plus an intravaginal insert containing 1.9 g of progesterone inserted at the time of the first GnRH injection and removed 7 d later. Progesterone-supplemented cows had a greater PR (31.2%) compared with controls (22.7%). Plasma progesterone concentrations at artificial insemination (AI) were <1 ng/mL and did not differ between treatments. At 14 d post-AI, however, more cows that received progesterone supplementation had concentrations of progesterone >1 ng/mL compared with controls. It was concluded that after a presynchronization period, cows subjected to the Ovsynch program and supplemented with exogenous progesterone had a greater PR and greater concentrations of progesterone after AI than those subjected to the Ovsynch protocol and not supplemented with progesterone.
Melendez
P
P
College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA. melendezp@mail.vetmed.ufl.edu
Gonzalez
G
G
Aguilar
E
E
Loera
O
O
Risco
C
C
Archbald
L F
LF
D000818:Animals; D002417:Cattle / Q000502:physiology*; D003612:Dairying / Q000379:methods*; D015237:Dinoprost / Q000008:administration & dosage; D004973:Estrus Synchronization / Q000379:methods*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D007315:Insemination, Artificial / Q000379:methods / Q000662:veterinary*; D016018:Least-Squares Analysis; D016015:Logistic Models; D010120:Oxytocics / Q000008:administration & dosage; D011247:Pregnancy; D018873:Pregnancy Rate; D011374:Progesterone / Q000008:administration & dosage / Q000494:pharmacology*; D011372:Progestins / Q000008:administration & dosage / Q000494:pharmacology; D011897:Random Allocation
D010120:Oxytocics; D011372:Progestins; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D015237:Dinoprost